# Maze Therapeutics, Inc.: filings

MAZE · Nasdaq · CIK 1842295 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/maze.md) · [Financials](/companies/maze/financials.md) · [Filings](/companies/maze/filings.md) · [Insiders](/companies/maze/insiders.md)

## Reports and events: 28 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 84, 144 25, 3 23, 8-K 16, SCHEDULE 13G/A 13, SCHEDULE 13G 10, CORRESP 6, UPLOAD 6, 10-Q 5, DRS/A 4, DRSLTR 3, 10-K 2, EFFECT 2, S-1 2, S-1/A 2, S-8 2, SEC STAFF LETTER 2, 424B3 1, 424B4 1, 424B5 1, 8-A12B 1, ARS 1, CERT 1, DEF 14A 1, DEFA14A 1, DRS 1, POS AM 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 16:05 ET | [8-K](/filings/0001193125-26-424067.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-424067 |
| 2026-08-17 | 16:16 ET | [8-K](/filings/0001193125-26-354092.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-354092 |
| 2026-08-11 | 16:48 ET | [10-Q](/filings/0001193125-26-344903.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344903 |
| 2026-08-11 | 16:45 ET | [8-K](/filings/0001193125-26-344878.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344878 |
| 2026-06-10 | 16:15 ET | [8-K](/filings/0001193125-26-265858.md) | 5.07 Shareholder vote results | 0001193125-26-265858 |
| 2026-05-22 | 17:24 ET | [8-K](/filings/0001193125-26-237199.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-237199 |
| 2026-05-12 | 16:11 ET | [10-Q](/filings/0001193125-26-219430.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219430 |
| 2026-05-12 | 16:07 ET | [8-K](/filings/0001193125-26-219398.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219398 |
| 2026-04-28 | 16:30 ET | [DEF 14A](/filings/0001140361-26-017463.md) | Proxy statement, period 2026-06-08 | 0001140361-26-017463 |
| 2026-04-22 | 16:56 ET | [8-K](/filings/0001193125-26-170701.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-170701 |
| 2026-03-25 | 07:11 ET | [10-K](/filings/0001193125-26-122778.md) | Annual report, period 2025-12-31 | 0001193125-26-122778 |
| 2026-03-25 | 07:08 ET | [8-K](/filings/0001193125-26-122774.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-122774 |
| 2026-02-04 | 16:45 ET | [8-K](/filings/0001193125-26-037747.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001193125-26-037747 |
| 2025-11-06 | 16:27 ET | [10-Q](/filings/0001193125-25-269689.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269689 |
| 2025-11-06 | 16:21 ET | [8-K](/filings/0001193125-25-269624.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269624 |
| 2025-10-17 | 16:15 ET | [S-1](/filings/0001193125-25-242526.md) | Registration statement | 0001193125-25-242526 |
| 2025-10-06 | 07:30 ET | [8-K](/filings/0001193125-25-230926.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-230926 |
| 2025-09-11 | 07:48 ET | [8-K](/filings/0001193125-25-200760.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-200760 |
| 2025-09-02 | 07:00 ET | [8-K](/filings/0001193125-25-193353.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-193353 |
| 2025-08-12 | 16:08 ET | [10-Q](/filings/0000950170-25-107306.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107306 |
| 2025-08-12 | 16:06 ET | [8-K](/filings/0000950170-25-107299.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-107299 |
| 2025-05-14 | 16:06 ET | [10-Q](/filings/0000950170-25-071375.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071375 |
| 2025-05-14 | 16:04 ET | [8-K](/filings/0000950170-25-071357.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-071357 |
| 2025-03-31 | 07:34 ET | [10-K](/filings/0000950170-25-047208.md) | Annual report, period 2024-12-31 | 0000950170-25-047208 |
| 2025-03-31 | 07:32 ET | [8-K](/filings/0000950170-25-047207.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047207 |
| 2025-01-30 | 06:57 ET | [S-1/A](/filings/0001193125-25-016039.md) | Registration statement, amended | 0001193125-25-016039 |
| 2025-01-27 | 06:07 ET | [S-1/A](/filings/0001193125-25-012638.md) | Registration statement, amended | 0001193125-25-012638 |
| 2025-01-07 | 16:16 ET | [S-1](/filings/0001193125-25-002851.md) | Registration statement | 0001193125-25-002851 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:22 ET. No prices; not investment advice.